¿Qué ha anunciado Oncomatryx contra el cáncer? Oncomatryx, la biotecnológica vizcaína que desarrolla fármacos contra tumores ...
The most difficult biological-security problem today is not simply the existence of biological weapons. It is the speed at ...
Leading biotechnology, public health, and science communication specialists had a two-day writeshop to equip local government leaders and public servants with science-based tools for agricultural ...
Moderna (NASDAQ: MRNA) has been one of the market's hottest stocks this year, surging more than 500% so far. The biotech stock has delivered these kinds of gains before, soaring m ...
Technological advancements in biotechnology and biological sciences are driving transformations across healthcare, ...
Viking's weight loss pill program has a couple of issues, including the fierce competitors who have a big head start.
The VanEck Biotech ETF (NASDAQ:BBH) offers concentrated exposure to large-cap biotech leaders, while the State Street SPDR S ...
In solid-tumor medicine, the cell doing the killing is often not the one you would bet on. A study published in Science ...
Vir Biotechnology’s T-cell engager ‘VIR-5500’ gets US FDA’s fast track designation to treat prostate cancer: San Francisco Saturday, October 10, 2026, 15:00 Hrs [IST] Vir ...
Careers for Pharmaceutical and Biotech Researchers | Research Job Hunting Seminar â‘«A researcher's career changes ...
Mohanty, who is also the secretary of the Department of Atomic Energy, was addressing the 36th convocation of the Birla ...
India is on the brink of a major technological transformation with advances in areas like artificial intelligence and quantum technologies opening up new possibilities, Atomic Energy Commission ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results